Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 63,299 |
|
|||||
| News | - | ||||||
| Day High | 0.2642 | Low High |
|||||
| Day Low | 0.23 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Portage Biotech Inc | PRTG | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0032 | 1.35% | 0.2402 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.2418 | 0.23 | 0.2642 | 0.2402 | 0.237 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 321 | 63,299 | $ 0.2378478 | $ 15,056 | - | 0.1999 - 4.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:27:57 | 89 | $ 0.24 | USD |
Portage Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 4.75M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Portage Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRTG Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.2855 | 0.35 | 0.229 | 0.2721514 | 224,490 | -0.0453 | -15.87% |
| 1 Month | 0.551 | 0.63999 | 0.1999 | 0.3150465 | 153,231 | -0.3108 | -56.41% |
| 3 Months | 0.80 | 0.80 | 0.1999 | 0.4395687 | 101,170 | -0.5598 | -69.98% |
| 6 Months | 1.89 | 2.17 | 0.1999 | 0.6882624 | 66,699 | -1.65 | -87.29% |
| 1 Year | 3.34 | 4.40 | 0.1999 | 1.16 | 42,847 | -3.10 | -92.81% |
| 3 Years | 28.15 | 44.9763 | 0.1999 | 8.56 | 36,267 | -27.91 | -99.15% |
| 5 Years | 37.50 | 44.9763 | 0.1999 | 8.95 | 35,019 | -37.26 | -99.36% |
Portage Biotech Description
| Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others. |
